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ABSTRACT 
Septic shock is a medical emergency which requires a 
supportive treatment with vasoactive agents to restore 
adequate blood pressure and tissue perfusion. Due to the 
complex medical conditions of septic patients, the 
identification of the best therapeutic approach remains 
one of the major challenges for the clinicians. Thus, an 
improved understanding of the pathophysiological 
mechanisms of septic shock is needed. A computer model 
provides a means of quantifying the key phenomena 
involved and identifying the potential therapeutic targets. 
This paper presents a comprehensive physiological and 
pharmacological model of the cardiovascular system that 
can simulate the hemodynamic response to vasoactive 
drugs with differing pharmacologic profiles. The model is 
used to study the interaction of combined noradrenaline 
and dobutamine therapy in patients with septic shock who 
typically remain hypotensive despite fluid administration.   
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1.  Introduction 
 
Septic shock is characterized by an overwhelming 
systemic response to bacterial infection and remains the 
leading cause of death in the intensive care units. This 
medical emergency (sepsis) occurs in three different 
forms which are the (1) uncomplicated sepsis that results 
from a known or suspected infection (2) severe sepsis 
which arises when sepsis occurs in combination with one 
vital organ dysfunction (3) septic shock occurs when 
sepsis is complicated with persistent hypotension that 
does not respond to fluid resuscitation.  
Patients with septic shock syndrome are characterized by 
severe physiologic abnormalities such as (1) peripheral 
arteriolar vasodilation which results in low systemic 
vascular resistance causing hypotension (2) increased 
vascular leakage and fluid loss from the intravascular 
space causing hypovolaemia and (3) myocardial 
depression with impaired systolic and diastolic function, 
noncompliant, dilated and poorly contractile ventricles 
[1]. After fluid resuscitation, parallel to reversing the 
underlying cause of infection, supportive treatment of 
septic patients with vaso-active medication is very often 
required to restore normal blood pressure and improve the 
circulatory performance. The most useful 
inotrope/vasopressor drugs in septic shock are dopamine, 
dobutamine, norepinephrine and epinephrine. Dobutamine 
has predominantly ß1 effects. It increases the contractility 
and heart rate and hence the cardiac output. It also has ß2 
effects which cause a mild vasodilatation and thus 
decreases the afterload. Noradrenaline, on the other hand, 
is very effective in rising arterial blood pressure through 
its potent vasoconstriction. Many clinical studies have 
reported that dobutamine used in conjunction with 
noradrenaline appears to be the optimal regimen in the 
therapeutic management of septic shock patients. 
The aim of this study is to model the interactions of these 
two drugs with the cardiovascular system in septic shock 
conditions. The model developed gives a good 
understanding of the hemodynamic abnormalities 
observed in septic patients and successfully predicts the 
response to different infusion rates of noradrenaline and 
dobutamine. 
 
The paper is organised as follows. First, the basic features 
of the model are presented. The model is subsequently 
used to simulate three classes of septic patients based on 
quantitative description of sepsis related hemodynamic 
abnormalities. Finally, the interaction of the model with 
noradrenaline and dobutamine is described.  
 
 
2.  Model Description 
 
The physiological model used in this study combines a 
pulsatile model of the cardiovascular mechanics with a 
pharmacological model which describes drug transport 
throughout the various parts of the body. Drug effects on 
the cardiovascular system are simulated as changes in the 
physiological model parameters based on published 
quantitative data [2]. The overall model structure is 
shown in Fig. 1.  
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Fig. 1. Structure of the Physiological Model. 
 
The cardiovascular system (CVS) model consists of 
fourteen compartments describing the systemic, 
pulmonary, coronary and cerebral circulations. Fig. 2 
shows the model layout.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Cardiovascular System Model Structure. 
 
Each compartment consists of a compliant element (C) 
and a resistance (R) as shown in Fig. 3. 
 
 
                                                   
 
 
 
Fig. 3. Electric Analog Model of a Compartment. 
 
The relationships between pressure (P), flow (Q) and 
volume (V) in a compartment are given as follows: 
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Where V0 denotes the unstressed volume of the relevant 
compartment. 
 
Flow into the circulation is maintained by a pulsatile 
cardiac pump where the right and left hearts are described 
by a time-varying elastance E(t) modeled with two Hill 
equations. The first bracket describes the ascending part 
of E(t) and the second the descending part of E(t). 
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The parameters 1n , 1n , Tα1 and Tα 2 are obtained from 
experimentally observed elastance.  
 
The mathematical model of the baroreflex has been 
adapted from [3]. The model includes the afferent carotid 
baroreflex pathway, the sympathetic and vagal efferent 
activities.  The effector sites of these nerve stimulations 
are the left and right ventricular maximum elastances, the 
heart period and the different peripheral arterial 
resistances. Fig. 4 depicts the structure of the baroreflex 
model.  
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Baroreceptor Firing Pathways. 
 
The drug transport model consists of the same number of 
compartments as the CVS and is used to calculate drug 
concentrations in the relevant body compartments. A 
single compartment representation is shown in Fig. 5. 
 
 
 
 
 
 
 
Fig. 5. Drug Transport Model Compartment. 
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Drug mass in each compartment is governed by the 
following equation: 
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where Mi+1 is the mass of drug in compartment (i+1), Ci 
and Ci+1 represent the inflow and outflow concentrations, 
Qi and Qi+1 are the inward (leaving the previous 
compartment) and outward blood flows respectively. 
Mi+1,0 denotes the mass of drug removed from that 
compartment. Drug elimination from the body is assumed 
to occur within each compartment. The instantaneous 
drug concentration is calculated as follows: 
 
       V/MC                                  (4) 
 
where V denotes the total blood volume (stressed and 
unstressed) available in the relevant compartment.  
 
The drug effect model relating the concentration of drug 
in the different compartments to the changes in the 
corresponding parameters values (resistances, 
compliances, elastances and heart rate) has been described 
by an exponential function. The parameters of the 
exponential function are optimised using the Levenberg-
Marquardt algorithm based on the available effect data 
given for noradrenaline and dobutamine respectively [2]. 
 
3. Pathophysiological Mechanisms of Sepsis 
 
Sepsis stimulates the release of potent inflammatory 
mediators into the circulation which induce vasodilatation 
of vascular smooth muscles and compromise the cardiac 
function by causing myocardial depression [4]. 
 
The theoretical pressure-volume loops corresponding to 
normal and septic patients are plotted in Fig. 6.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6. Pressure-volume   loops   for   normal   patient 
(bold), survivors (dotted) and non-survivors dashed) 
[5]. 
 
Emax represents the slope of the end systolic pressure 
volume relationship and is assimilated to the ventricle 
contractility.  In survivors of severe sepsis, an adequate 
stroke volume is maintained in the early stage by an 
increase in the end diastolic volume. In nonsurvivors, 
failure to increase the end diastolic compliance results in 
inability to maintain the same stroke volume [5]. These 
alterations in ventricular function and size are transient 
and return to normal in survivors usually after 7 to 10 
days. 
 
4. Simulation Results 
 
The baseline parameters of the CVS model correspond to 
a human subject of 75 Kg with a total blood volume of 
5.6 liters and a heart rate of 75 beats/min [6]. For 
integration the Euler method was used with a step size 
initially set to 0.005 sec. and subsequently adjusted with 
changing heart rates. Initial compartment volumes have 
been calculated for each compartment as the sum of the 
unstressed volume and the volume given by the 
integration procedure (i.e. the stressed volume). 
Fig. 7 shows the simulated left and right ventricle 
pressures and the aortic and pulmonary pressures related 
to a normal subject.  
 
Fig. 7. Simulated left and right ventricles, aortic and 
pulmonary pressures of a normal subject. 
 
Under normal conditions, the compensatory response to 
hypotension is mediated by a sympathetic activation of 
the heart and peripheral vessels which restores the arterial 
blood pressure to its normal value. The onset of severe 
sepsis is accompanied by an impairment of the 
autonomous nervous system leading to a compromised 
baroreflex function with a deregulation in the sympathetic 
and parasympathetic activities. Therefore, to better 
illustrate the interaction between drugs and the 
physiological model, the baroreflex has been excluded in 
this simulation study. 
 
For simulation purposes, the model has been 
parameterized to describe three categories of septic 
patients: mild, moderate and severe. The simulated 
pressure-volume curves under mild, moderate and severe 
sepsis conditions are plotted in Fig. 8. The pressure-
volume loops are lowered as a result of a decreasing 
afterload (vasodilatation) and shifted to the right as a 
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result of a decreased contractility (myocardial 
depression). 
 
The three hypothetical models of septic patients are 
considered separately to evaluate the interaction of 
combined infusions of noradrenaline and dobutamine. 
 
Fig. 8. Left  ventricle  pressure-volume loops  related 
to the three classes of simulated septic patients. 
 
In the subsequent simulations noradrenaline and 
dobutamine half-lives have been taken equal to 90 sec and 
120 sec respectively. Noradrenaline infusion is started at 
time 200 sec while dobutamine infusion begins at 1000 
sec. A time delay of 30 sec has been assumed between the 
commencement of infusion and the onset of action, this 
being deemed to be reasonable. 
  
4.1 Mild Sepsis 
 
Noradrenaline and dobutamine infusions rates were set to 
0.15g/kg/min and 5g/kg/min respectively. The results 
are shown in Fig. 9.  
 
Fig. 9. Hemodynamic   response of a subject under  mild 
sepsis. 
 
Noradrenaline produces a marked increase in the SVR 
due to its vasoconstricting potency which results in an 
improved MAP. The heart rate is increased and 
consequently this result is a fall in stroke volume. At this 
stage, all hemodynamic variables have reached reasonable 
steady-state values. The inotropic effect of dobutamine is 
expected to increase the cardiac output through its direct 
effect on the ventricle contractility. It also causes an 
increase in the heart rate and a mild vasodilatation. 
 
Fig. 10 shows the left ventricle pressure and aortic blood 
pressure during simultaneous infusion of the two drugs. 
 
 
 
Fig. 10. Left   ventricle  pressure  and  aortic pressure 
related a subject with a mild sepsis. 
 
4.2 Moderate Sepsis 
 
Vasodilatation and hypotension are more pronounced for 
this category of simulated septic patient hence requiring a 
higher dose of noradrenaline. The infusion rates were set 
to 0.25g/kg/min for noradrenaline and 2.5g/kg/min for 
dobutamine. The results obtained are shown in Fig. 11. 
All the hemodynamic parameters were normalized 
accordingly. 
 
 
 
Fig. 11. Hemodynamic   response   of  a  subject with 
moderate sepsis. 
 
The left ventricle and aortic pressures are shown in Fig. 
12.  
 
 
Fig. 12.  Left  ventricle  pressure  and  aortic pressure 
related a subject with a moderate sepsis. 
 
4.3 Severe Sepsis 
 
The same protocol is applied to this category of simulated 
septic patient. The infusion rates used for noradrenaline 
and dobutamine are 0.8g/kg/min and 2g/kg/min 
respectively. The results of Fig. 13, show an improved 
MAP trace following noradrenaline infusion. There is a 
marked increase in the cardiac output and high 
tachycardia due to the chronotropic effects of these two 
drugs.   
 
 
 
Fig. 13. Hemodynamic  response  of  a  subject   with 
severe sepsis. 
   
Fig. 14 shows the left ventricle and aortic pressures in the 
case of a severe sepsis.  
 
Fig. 14.  Left  ventricle  pressure  and  aortic pressure 
related a subject with a severe sepsis. 
 
 
Table 1 Steady-state hemodynamics after noradrenaline 
and dobutamine infusions 
 
Patient CO HR SV MAP SVR 
1 6.3 97 65 107 1352 
2 6.4 112 57.6 105 1298 
3 6.5 140 46.5 113 1391 
 
Where CO=cardiac output (l/min), HR=heart rate 
(beats/min), SV= stroke volume (ml/beat), MAP=mean 
arterial pressure (mmHg) and SVR=systemic vascular 
resistance (dynes/min/l). 
 
The pressure-volume curves related to the three septic 
patient models considered in this study are plotted in Fig. 
15 (see Fig. 8).  The results of Fig. 15 reflect a successful 
reversal of the hemodynamic abnormalities characterising 
septic shock. A further improvement of the hemodynamic 
status requires returning the heart rate to normal using 
additional medication. 
 
Fig. 15.  Left    ventricle     pressure-volume    curves 
related to the three classes of septic patients after drug 
infusions. 
 
5.  Conclusion 
 
The physiological model described in this research study 
succeeded in simulating the hemodynamic response of a 
wide range of patients with sepsis and assess the 
pharmacological effects of various vasoactive drugs. The 
classes of patient models considered here have been 
parameterized based on the (the 3rd author) clinician’s 
quantitative description of the key features of septic 
shock. The models successfully reproduced the 
therapeutic effects of noradrenaline and dobutamine 
observed in clinical practice. It is envisaged to validate 
the model using real-time clinical data in the near future.  
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